Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial - Concepedia

Concepedia

Publication | Open Access

Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial

DOI Full Paper Access

35

Citations

167

References

2016

Year

Deepti Saxena, Michael Spino, Fernando Tricta, John Connelly, Bernadette Cracchiolo, Axel-Rainer Hanauske, Darlene D’Alliessi Gandolfi, Michael B. Mathews, Jonathan Karn, Bart Holland,

Abstract

ClinicalTrial.gov NCT02191657.

References

	Year	Citations

Page 1